EmbarkNeuro
PrivateLast Round
Seed
Jun 30, 2021
Company Overview
EmbarkNeuro is a biotechnology company focused on developing personalized treatments for mental health disorders, specifically targeting the stress-response system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EmbarkNeuro Comparables
Compare EmbarkNeuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HMNC Brain Health | 77% | |
| Spruce Biosciences | 77% | |
| Alto Neuroscience | 73% |
EmbarkNeuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 30, 2021 |
EmbarkNeuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aditum Bio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2021
Led by Aditum Bio with participation from Taisho Pharmaceutical.
EmbarkNeuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EmbarkNeuro's valuation, stock price, and market status.
Is EmbarkNeuro a public or private company?
EmbarkNeuro is a private company.
What is the current stock price of EmbarkNeuro?
EmbarkNeuro is a private company with no public stock price. No recent secondary market data is available.
How much is EmbarkNeuro worth (valuation)?
Valuation information for EmbarkNeuro is not publicly available.
Can I buy EmbarkNeuro stock?
EmbarkNeuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EmbarkNeuro's last funding round?
EmbarkNeuro's most recent funding round was Seed on June 30, 2021.
Who are the main investors in EmbarkNeuro?
Key investors in EmbarkNeuro include Aditum Bio.
Will EmbarkNeuro IPO soon?
No public IPO plans have been announced for EmbarkNeuro.
How can I track EmbarkNeuro secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EmbarkNeuro's secondary market activity and sign up for updates.